Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

DSpace Repository

Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

Author: Paraiso, Kim H. T.; Das Thakur, Meghna; Fang, Bin; Koomen, John M.; Fedorenko, Inna V.; John, Jobin K.; Tsao, Hensin; Flaherty, Keith T.; Sondak, Vernon K.; Messina, Jane L.; Pasquale, Elena B.; Villagra, Alejandro; Rao, Uma N.; Kirkwood, John M.; Meier, Friedegund; Sloot, Sarah; Gibney, Geoffrey T.; Stuart, Darrin; Tawbi, Hussein; Smalley, Keiran S. M.
Tübinger Autor(en):
Meier, Friedegund
Published in: Cancer Discovery (2015), Bd. 5, H. 3, S. 264-273
Verlagsangabe: Amer Assoc Cancer Research
Language: English
Full text: http://dx.doi.org/10.1158/2159-8290.CD-14-0293
ISSN: 2159-8274
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)